Skip to content

Patient-Centered Implementation Trial for Single Embryo Transfer

Patient-Centered Implementation of Elective Single Embryo Transfer (eSET) in in Vitro Fertilisation (IVF) and Intracytoplasmic Sperm Injection (ICSI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00315029
Enrollment
230
Registered
2006-04-17
Start date
2006-11-30
Completion date
2008-10-31
Last updated
2008-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Infertility, Male Infertility, Pregnancy

Keywords

Implementation, Single embryo transfer, ICSI, IVF, prevention

Brief summary

Background: The number of multiple pregnancies is considered to be the most important adverse effect of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). IVF or ICSI with transferring only one embryo, elective single embryo transfer (eSET), will reduce this incidence remarkably. Unfortunately, former research has documented that cycles with SET maintain lower pregnancy rates compared to double embryo transfer (DET). Implementation of eSET will require a carefully chosen and thoroughly defined implementation strategy focussed on the couple undergoing the subfertility treatment. This trial will investigate the (cost)effectiveness of a combined patient centred implementation strategy. Objective: The main aim is to compare the effectiveness and costs of implementation of elective single embryo transfer (eSET) in in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI), between usual care and a combined patient-centred strategy. Study design: A randomised controlled trial Study population: Couples with a female age less than 40 years ongoing an IVF/ICSI treatment in 2 of the 13 Dutch IVF centres and their 4 satellite/transport centres. Intervention A combined patient centred implementation strategy for eSET in IVF/ICSI. The strategy consists of counselling through an evidence based decision aid and reimbursement of a 4th cycle if couples have chosen for eSET in the first 2 cycles. Primary study parameters/outcome of the study: the eSET occurrence rate, pregnancy outcomes and cost-effectiveness of the combined strategy. Secondary study parameters/outcome of the study: * patient knowledge * patient decisional conflict * patient satisfaction * IVF/ICSI treatment outcome.

Detailed description

see above

Interventions

BEHAVIORALevidence based decision aid

evidence based decision aid

BEHAVIORALPossible reimbursement 4th IVF/ICSI cycle when necessary

Potential reimbursement 4th IVF/ICSI cycle when necessary

Sponsors

ZonMw: The Netherlands Organisation for Health Research and Development
CollaboratorOTHER
Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Female age \< 39 years * In first cycle minimum of two embryos available for transfer

Exclusion criteria

* Medical necessity for single embryo transfer

Design outcomes

Primary

MeasureTime frame
Incidence choice for eSETafter embryo transfer

Secondary

MeasureTime frame
Patient knowledgeduring treatment
patient decisional conflictduring treatment
Patient experiencesduringg treatment
Pregnancy outcomesafter treatment
Cost-effectivenessafter follow up

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026